Back to search

Article

Modified Sanliangsan improved Sjogren’s syndrome complicated with interstitial lung disease by suppressing serum MUC1 levels

2024-04-26

Abstract excerpt

<title>Abstract</title> <p>Objectives To clarify if the mechanism of Sanliangsan in improving Sjogren’s syndrome complicated with interstitial lung disease (SS-ILD) involves MUC1 suppression, which is involved in SS-ILD pathogenesis. Methods Fifty-six patients were randomly divided into two groups receiving Sanliangsan prescription therapy and conventional therapy. In-depth transcriptome profiles collected and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
afec1145-3970-5632-938b-c4e81a5ec8cb
DOI
10.21203/rs.3.rs-4279300/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modified Sanliangsan improved Sjogren’s syndrome complicated with interstitial lung disease by suppressing serum MUC1 levelsDOI 10.21203/rs.3.rs-4279300/v1
Select a neighboring publication to make it the new centre.